“We were able to reach the starting line of a new medical therapy,” said Dr Ryuichi Okamoto about the new regenerative treatment for ulcerative colitis.
iPS cells are moving from clinical trialsーeye disease, Parkinson’s disease, heart failure, cancer, spinal cord injuriesーto the stage of practical application.
Few manufacturers — such as Japan’s Eisai and the U.S.’ Biogen — have continued to develop a treatment. We hope the health ministry announces the approval...
Graduate student’s study of how sea slugs regenerate their lost, damaged or cut-off parts can be unraveled could bring new hope to regenerative medicine for humans.
iPS cell research is moving ahead quickly with promising applications for COVID-19, diseases affecting vision and muscular function, among others. The issue to overcome next is...
Getting started with the world of ukiyo-e can feel a bit daunting. After all, how does one even begin to understand the art of...
